Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIDI Quantification of Performance Change in Musician's Dystonia After Botulinum Toxin Type B
NCT00208091Phase 4Completed
- Sponsor
- Columbia University
- Start
- Apr 2003
- Primary completion
- May 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type b in focal dystonia, sponsored by Columbia University. Started Apr 2003; status: completed.
02
Drugs
botulinum toxin type b
03
Conditions
focal dystonia
Beyond the preview
Go deeper on NCT00208091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00208091.